These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7662604)

  • 1. Effects of captopril on plasma endothelin-1 during thrombolysis: preliminary findings.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Caracausi R; Pipitone F; Licata G
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):359-60. PubMed ID: 7662604
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril does not affect plasma endothelin-1 during thrombolysis and reperfusion.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Cannizzaro S; Pipitone F; Maringhini G; Scalzo S; Licata G
    Int J Cardiol; 1995 Sep; 51(2):131-5. PubMed ID: 8522408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the administration of captopril, metoprolol and of the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction.
    Di Pasquale P; Paterna S; Bucca V; Maringhini G; Magatti M
    Int J Cardiol; 1994 Sep; 46(2):107-12. PubMed ID: 7814158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.
    Nabel EG; Topol EJ; Galeana A; Ellis SG; Bates ER; Werns SW; Walton JA; Muller DW; Schwaiger M; Pitt B
    J Am Coll Cardiol; 1991 Feb; 17(2):467-73. PubMed ID: 1825097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does plasma endothelin during thrombolysis depend on infarct size? A pilot study.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Pipitone F; Tricoli G; Licata G
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):831-2. PubMed ID: 8850391
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activators (rtPA): a review.
    Gurman P; Miranda OR; Nathan A; Washington C; Rosen Y; Elman NM
    Clin Pharmacol Ther; 2015 Mar; 97(3):274-85. PubMed ID: 25670034
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of administration of captopril, metoprolol, and the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction.
    Di Pasquale P; Paterna S; Bucca V; Licata G
    Cardiovasc Drugs Ther; 1994 Dec; 8(6):875-6. PubMed ID: 7742267
    [No Abstract]   [Full Text] [Related]  

  • 8. Early captopril treatment reduces plasma endothelin concentrations in the acute and subacute phases of myocardial infarction: a pilot study.
    Di Pasquale P; Valdes L; Albano V; Bucca V; Scalzo S; Pieri D; Maringhini G; Paterna S
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):202-8. PubMed ID: 9057069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful thrombolysis for acute myocardial infarction in Type I von Willebrand's disease (vWD).
    Fragasso G; Camba L; Pizzetti G; Pagnotta P; Chierchia SL
    Am J Hematol; 1998 Feb; 57(2):180. PubMed ID: 9462554
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
    Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
    J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model.
    Nishiyama H; Umemura K; Saniabadi AR; Takiguchi Y; Uematsu T; Nakashima M
    Eur J Pharmacol; 1994 Oct; 264(2):191-8. PubMed ID: 7851482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of captopril on plasma endothelin and calcitonin gene related peptide (CGRP) in patients with acute myocardial infarction].
    Zhang JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):363. PubMed ID: 1307977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?].
    Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Longo AM; Alessi V; D'Amato M; Manusia F; Magatti MF
    G Ital Cardiol; 1996 Jun; 26(6):673-80. PubMed ID: 8803588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group.
    Zeymer U; von Essen R; Tebbe U; Niederer W; Mäurer W; Vogt A; Neuhaus KL
    Am J Cardiol; 1995 Nov; 76(14):997-1001. PubMed ID: 7484879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
    Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.
    Wright RA; Flapan AD; Alberti KG; Ludlam CA; Fox KA
    J Am Coll Cardiol; 1994 Jul; 24(1):67-73. PubMed ID: 8006284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
    Santos Filho RD; Tranchesi Júnior B; Caramelli B; Barbosa V; Gebara O; de Albuquerque CP; Vinagre C; Maranhão R; Pileggi F
    Arq Bras Cardiol; 1991 Jul; 57(1):9-12. PubMed ID: 1823766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.